Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
12/2000
12/14/2000WO2000075137A1 Pyrrolidinyl, piperidinyl or homopiperidinyl substituted (benzodioxan, benzofuran or benzopyran) derivatives
12/14/2000WO2000075136A1 Aminoalkyl substituted (benzodioxan, benzofuran or benzopyran) derivatives
12/14/2000WO2000075107A2 Bradykinin receptor antagonists
12/14/2000WO2000074724A2 Conjugates comprising cytokines and nucleic acids for treating proliferating cells
12/14/2000WO2000074718A1 Immunotherapy of autoimmune disorders using antibodies which target b-cells
12/14/2000WO2000074712A2 Composition comprising alkaline sphingomyelinase for use as a dietetic preparation, food supplement or pharmaceutical product
12/14/2000WO2000074707A2 Use of interleukin-11 to treat hemorrhagic shock
12/14/2000WO2000074706A1 Therapeutic use of an inhibitor of a hedgehog or a hedgehog-related signalling pathway
12/14/2000WO2000074689A1 Unfermented gel fraction from psyllium seed husks
12/14/2000WO2000074681A1 Metalloprotease inhibitors
12/14/2000WO2000074670A1 USE OF VERAPAMIL AND VERAPAMIL DERIVATIVES FOR PRODUCING MEDICAMENTS WITH AN INHIBITING EFFECT ON β-GLUCURONIDASE IN HUMAN TISSUE
12/14/2000WO2000074652A1 Pharmaceutical composition for nasally administering water-soluble active substances
12/14/2000WO2000074651A1 Pharmaceutical composition for intranasal use of active substances that are insoluble and/or hardly soluble in water
12/14/2000WO2000074497A1 The combined use of triglycerides containing medium chain fatty acids and exogenous lipolytic enzymes as feed supplements
12/14/2000WO2000063208B1 Substituted imidazoles, their preparation and use
12/14/2000WO2000048624A3 Utilization of orosomucoid in order to produce a pharmaceutical preparation
12/14/2000WO2000047284A3 Novel use of orexin receptor antagonists
12/14/2000WO2000047231A3 Novel antisense inhibition of rad51
12/14/2000WO2000044348A3 Materials and methods for making improved micelle compositions
12/14/2000WO2000043498A3 Human liver progenitors
12/14/2000WO2000042063A3 Peptides for inhibiting hbv core proteins
12/14/2000DE19925810A1 Anwendung von Verapamil und Verapamilderivaten zur Herstellung von Arzneimitteln mit Glucuronidase hemmender Wirkung Application of verapamil and Verapamilderivaten for producing drugs with glucuronidase inhibiting action
12/14/2000CA2383828A1 26 human secreted proteins
12/14/2000CA2376506A1 Neuromedin b and somatostatin receptor agonists
12/14/2000CA2376400A1 Compounds and methods to enhance raav transduction
12/14/2000CA2376358A1 Use of interleukin-11 to treat hemorrhagic shock
12/14/2000CA2376210A1 Therapeutic use of an inhibitor of a hedgehog or a hedgehog-related signalling pathway
12/14/2000CA2376199A1 Use of verapamil and verapamil derivatives for producing medicaments with an inhibiting effect on .beta.-glucuronidase in human tissue
12/14/2000CA2376048A1 Composition comprising alkaline sphingomyelinase for use as a dietetic preparation, food supplement or pharmaceutical product
12/14/2000CA2376039A1 Bioreactor design and process for engineering tissue from cells
12/14/2000CA2375912A1 Immunotherapy of autoimmune disorders using antibodies which target b-cells
12/14/2000CA2375882A1 Metalloprotease inhibitors
12/14/2000CA2375734A1 Benzothiazinone and benzoxazinone compounds
12/14/2000CA2375485A1 Method for multiplying stem cells
12/14/2000CA2375149A1 Apo-2l receptor agonist and cpt-11 synergism
12/14/2000CA2374558A1 Phospholipid transfer protein
12/13/2000EP1059041A1 The combined use of triglycerides containing medium chain fatty acids and exogenous lipolytic enzymes as feed supplements
12/13/2000EP1058691A1 Caspase-8 interacting proteins
12/13/2000EP1058683A1 Farnesyl transferase inhibitors having a piperidine structure and process for preparation thereof
12/13/2000EP1058681A1 Novel allylthiopyridazine derivatives and process for preparing the same
12/13/2000EP1058680A1 2-arylethyl-(piperidin-4-ylmethyl)amine derivatives as muscarinic receptor antagonists
12/13/2000EP1058544A1 Inhibition of tnf activity
12/13/2000EP1058535A1 Desensitizing dental composition
12/13/2000EP0680334B1 Morphogen treatment of gastrointestinal ulcers
12/13/2000EP0601062B2 Sirs vaccine and diagnosis method
12/13/2000CN1276790A Carboxamidothiazole derivs., preparation, pharmaceutical composition contg. them
12/13/2000CN1276785A N-aroylphenylalanine derivs.
12/13/2000CN1276784A Cyclic amino acids and derivs. thereof useful as pharmaceutical agents
12/13/2000CN1276782A 2-aminotetralines, process for their preparation, and pharmaceutical compositions, for prevention and therapeutic treatment of inflammatory and/or autoimmune pathologies
12/13/2000CN1276732A Composition for controlling bacterial colonization
12/13/2000CN1276730A Use of IFN-alpha and amantadine for treatment of chronic hepatitis C
12/13/2000CN1276721A Use of 6,7-substd. 2-aminotetralines suitable for preparing pharmaceutical composition for therapeutic treatment of inflammatory and/or autoimmune pathologies
12/13/2000CN1276238A Food for treating diarrhea
12/13/2000CN1276230A Chinese medicine preparation for treating piles and its preparing process
12/13/2000CN1276224A Medicine for curing infectious gastrosis and its preparing process
12/13/2000CN1276221A Anal fissure ointment and its preparing process
12/13/2000CN1276217A Capsule for warming-up stomach and reinforcing function of heart, spleen or kidney
12/13/2000CN1276212A Functional oligose food
12/13/2000CN1276211A Use of non-peptides NK3-antagonist
12/13/2000CN1059330C Use of sophora fruit in medicine for treatment of tonsillitis
12/12/2000US6160175 Naphthyl acetamides as sPLA2 inhibitors
12/12/2000US6160119 Fused dihydropyrans
12/12/2000US6160087 Peptides having an amino acid sequence from the fimbrial protein of porphyromonas gingivalis and their uses
12/12/2000US6160009 Excitatory amino acid receptor modulators
12/12/2000US6159998 Administered as vasodilators, analgesics, anesthetics, sedatives, and anitspasmodic agents
12/12/2000US6159995 Substituted diaminocarboxylic acids
12/12/2000US6159983 Method and composition for treatment of inflammatory bowel disease
12/12/2000US6159955 Use of hyaluronic acid and a NSAID for the manufacture of a medicament for the treatment of mucosal diseases
12/12/2000US6159935 Method for preventing diarrhea
12/12/2000US6159734 Nucleotide sequences which prevent or reduce transcription of human gene; for the treatment of non-insulin dependent diabetes, cardiovascular disorders and gastrointestinal disorders; antiinflammatory agents; anticarcinogenic agents
12/12/2000US6159451 Manufacturing process of glucosyltransferase inhibitors from cacao bean husk
12/12/2000US6159450 Use of Ginkgo biloba flavonoidic extract substantially devoid of terpenes for oral hygiene and composition containing such extract
12/12/2000US6159447 In oral cavity; immobilized enzyme
12/12/2000CA2168247C Nitric oxide donor composition and method for treatment of anal disorders
12/07/2000WO2000073507A2 Identification of a novel retrovirus associated with primary biliary cirrhosis and autoimmune disorders
12/07/2000WO2000073450A2 Cytoskeleton-associated proteins
12/07/2000WO2000073449A1 Dna encoding snorf33 receptor
12/07/2000WO2000073443A1 Lipid metabolism transcription factor
12/07/2000WO2000073342A1 Structural models for cytoplasmic domains of transmembrane receptors
12/07/2000WO2000073336A1 Fimbrial proteins
12/07/2000WO2000073334A2 Human sorting nexins
12/07/2000WO2000073327A1 Chemokine receptor ccr3 antagonists
12/07/2000WO2000073324A2 Modulation of gene expression in gastrointestinal inflammation
12/07/2000WO2000073321A1 Human tumor necrosis factor receptor tr10
12/07/2000WO2000073307A2 Substituted 8-phenylxanthines useful as antagonists of a2b adenosine receptors
12/07/2000WO2000073304A1 Polymorphs of a crystalline azabicyclo (2,2,2) octan-3-amine citrate and their pharmaceutical compositions
12/07/2000WO2000073303A1 Polymorphs of crystalline (2-benzhydryl-1-azabicyclo[2.2.2]oct-3-yl)-(5-isopropyl-2-methoxybenzyl)-amine citrate as nk-1 receptor antagonists
12/07/2000WO2000073302A1 Oxazaheterocycles as protease inhibitors
12/07/2000WO2000073296A2 3-heteroarylalkyl substituted gaba analogs
12/07/2000WO2000073295A1 3-(arylsulfonylamino)-tetrahydropyran-3-carboxylic acid hydroxamides
12/07/2000WO2000073294A2 3-(arylsulfonylamino)-tetrahydrofuran-3-carboxylic acid hydroxamides
12/07/2000WO2000073280A1 Cathecol hydrazone derivatives, process for preparing the same and pharmaceutical composition containing the same
12/07/2000WO2000073279A1 4-phenyl-pyrimidine derivatives
12/07/2000WO2000073278A2 5-phenyl-pyrimidine derivatives
12/07/2000WO2000072885A2 Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues
12/07/2000WO2000072881A1 A blocking monoclonal antibody to vla-1 and its use for the treatment of inflammatory disorders
12/07/2000WO2000072876A2 Prevention and treatment of amyloidogenic disease
12/07/2000WO2000072861A1 Pharmaceutical preparations of bioactive substances extracted from natural sources
12/07/2000WO2000072845A1 Il-8 receptor antagonists
12/07/2000WO2000072840A1 Il-8 receptor antagonists
1 ... 1058 1059 1060 1061 1062 1063 1064 1065 1066 1067 1068 1069 1070 1071 1072 1073 1074 1075 1076 1077 1078 ... 1258